Investors & Media

Overview

Corporate Profile

bluebird bio is a clinical-stage biotechnology company focused on transforming the lives of patients with severe genetic and orphan diseases using gene therapy. The company’s mission is to advance the care of patients with life threatening diseases worldwide. Headquartered in Cambridge, Massachusetts, bluebird bio has operations in the U.S. and Europe.

stock quote

NASDAQ: BlUE (common stock)

Refresh Quote
ExchangePriceChange (%)Volume
NASDAQ GS (US Dollar)
$133.36
 Stock is Up 3.69 (2.85%)
723,829
Data provided by Nasdaq. Minimum 15 minutes delayed.

Investor Contact

Manisha Pai

Sr. Director, Investor Relations

(617) 245-2107

investor@bluebirdbio.com


Media Contact

Dan Budwick

Senior Vice President, Media Relations

Pure Communications Inc.

(973) 271-6085

dan@purecommunicationsinc.com